LOSATUXIZUMAB
UNII 28TZY9G26X

Substance Identification & Data

This profile provides standardized clinical and technical data for Losatuxizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 28TZY9G26X.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1801544-27-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
28TZY9G26X
CAS Registry Number
1801544-27-3
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
LOSATUXIZUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C166557
National Cancer Institute reference terminology for clinical and research data.
INN ID
10409
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Losatuxizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LOSATUXIZUMAB

Common Names & Synonyms

LOSATUXIZUMAB [INN]

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR DE2-7 ISOFORM) (HUMAN-MUS MUSCULUS MONOCLONAL ABT-806-AM-1 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL ABT-806-AM-1 LIGHT CHAIN, DIMER

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus